MiR-199a mediated the dissemination of human mantle cell lymphoma by interacting with the CCR7/CCL21 pair-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MiR-199a mediated the dissemination of human mantle cell lymphoma by interacting with the CCR7/CCL21 pair

Published:2018-10 Issue:9 Volume:29 Page:861-870
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Li Weiming,Xue Weili,Wang Xinhua,Fu Xiaorui,Sun Zhenchang,Li Zhaoming,Chang Yu,Zhang Xudong,Zhou Zhiyuan,Chen Changying,Zhang Mingzhi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference32 articles.

1. Progress in mantle-cell lymphoma;Martin;J Clin Oncol,2009

2. Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysis;Schulz;J Natl Cancer Inst,2007

3. Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma;Robak;N Engl J Med,2015

4. Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial;Wang;Lancet,2016

5. Lymphoma dissemination: the other face of lymphocyte homing;Pals;Blood,2007

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Multi-Functional Roles of CCR7 in Human Immunology and as a Promising Therapeutic Target for Cancer Therapeutics;Frontiers in Molecular Biosciences;2022-07-06

2. Diagnosis and treatment of lymphomas in the era of epigenetics;Blood Reviews;2021-07

3. Circulating Tumor Cells: Does Ion Transport Contribute to Intravascular Survival, Adhesion, Extravasation, and Metastatic Organotropism?;From Malignant Transformation to Metastasis;2021

4. Circulating miRNAs as Biomarkers in Aggressive B Cell Lymphomas;Trends in Cancer;2020-11

5. miR-100 inhibits cell proliferation in mantle cell lymphoma by targeting mTOR;Experimental Hematology & Oncology;2020-09-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3